Friday | 5 December, 2008
Australian Biotechnology News

Stories about: Ortho Biotech

  • +

    Late stage partnerships not always the way to go: Edwards 29/09/2004 14:26:32

    Recombinant Capital's Mark Edwards has some unfashionable advice for Australian life science companies: don't hold out for a late-stage partnership with a pharmaceutical company at the expense of shoring up the company's future with early stage deals.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links